NEURALSTEM, INC. : Regulation FD Disclosure (form 8-K)

Item 7.01 Regulation FD Disclosure.

As of January 23, 2020, Seneca Biopharma, Inc. has 8,330,720 shares of its common stock, par value $0.01, issued and outstanding.

The information contained in this Item 7.01 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information or such exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses